Publications by authors named "K Winckers"

Background: Small-molecule inhibitors (SMIs) have revolutionised the treatment of non-small cell lung cancer (NSCLC). However, SMI-induced drug-drug interactions (DDIs) with frequently co-administered direct oral anticoagulants (DOACs), increase thromboembolic and bleeding risks. This study investigated and proactively managed the consequences of DOAC-SMI DDIs.

View Article and Find Full Text PDF
Article Synopsis
  • Direct oral anticoagulants (DOACs) have largely replaced warfarin for preventing and treating blood clots and reducing stroke risk in patients with atrial fibrillation.
  • While DOACs offer fixed dosing and convenience, they aren't suitable for high-thrombotic risk patients (like those with antiphospholipid syndrome or mechanical heart valves) and require careful consideration in patients with cancer or kidney issues.
  • New reversal agents for severe bleeding have been developed, and research on safer anticoagulants like factor XI(a) inhibitors is ongoing to improve treatment for elderly and frail individuals.
View Article and Find Full Text PDF

Background: Despite the low rate of bacterial coinfection, antibiotics are very commonly prescribed in hospitalized patients with COVID-19.

Research Question: Does the use of a procalcitonin (PCT)-guided antibiotic protocol safely reduce the use of antibiotics in patients with a COVID-19 infection?

Study Design And Methods: In this multicenter cohort, three groups of patients with COVID-19 were compared in terms of antibiotic consumption, namely one group treated based on a PCT-algorithm in one hospital (n = 216) and two control groups, consisting of patients from the same hospital (n = 57) and of patients from three similar hospitals (n = 486) without PCT measurements during the same period. The primary end point was antibiotic prescription in the first week of admission.

View Article and Find Full Text PDF